RWB
GBT

RMR Wealth Builders’s Global Blood Therapeutics, Inc. GBT Stock Holding History

RMR Wealth Builders’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-400
Closed -$16K – 772
2021
Q1 		$16K Sell
400
-250
-38% -$11.5K ﹤0.01% 549
2020
Q4 		$28K Buy
+650
New +$32K 0.01% 322
2020
Q3 		– Sell
-300
Closed -$19K – 483
2020
Q2 		$19K Buy
+300
New +$20.6K 0.02% 312
2019
Q4 		$24K Buy
+300
New +$17.8K 0.02% 302

Other funds holding GBT

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

RMR Wealth Builders's GBT Position: Q2 2021 in Review

RMR Wealth Builders sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2021, closing a stake of 400 shares — an estimated $16K sold.

RMR Wealth Builders first reported a position in GBT in Q4 2019 and held it in 4 quarters. The position peaked at $28K in Q4 2020. 192 funds tracked by Wall St. Rank hold GBT as of Q2 2021.

  • RMR Wealth Builders reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • RMR Wealth Builders sold 400 Global Blood Therapeutics, Inc. shares in Q2 2021, an estimated $16K.
  • RMR Wealth Builders first reported a position in Global Blood Therapeutics, Inc. in Q4 2019 and held it in 4 quarters.
  • RMR Wealth Builders's Global Blood Therapeutics, Inc. position peaked at $28K in Q4 2020.
  • 192 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2021.

Based on RMR Wealth Builders's 13F filing for Q2 2021, filed 16 Aug 2021.